Agreement – March 14, 2025
Salipro Biotech and Boehringer Ingelheim enter research and license agreement
This collaboration aims to advance the discovery and development of new therapeutic solutions targeting G protein-coupled receptors (GPCRs), ion channels, transporters and other integral membrane proteins in therapeutic areas such as mental health and cardio-renal-metabolic diseases.